NORTH WEST LUNG CENTRE

Registered charity 1090320 · accounts filings on the Charity Commission register

Promoting and assisting with the funding of research into lung disease in the North West of England

Objects

1) TO PROMOTE RESEARCH INTO THE COURSES AND TREATMENT OF HUMAN DISEASES AND TO DISSEMINATE THE SAVE TO THE PUBLIC AND DISTRIBUTION.2) TO ENGAGE IN RESEARCH AND DEVELOPMENT OF RESPIRATORY MEDICINES AND GENERAL MEDICINES FOR USE IN CONJUCTION WITH THE TREATMENT REFERRED TO IN 1) ABOVE3) TO PROMOTE THE HEALTH AND WELL BEING OF PATIENTS WITH RESPIRATORY OR RELATED DISEASES

Area of benefit: NOT DEFINED

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · Get email alerts

Registered contact address: Trafford, North West, England (from the postcode on the register)

Latest income
£20.9m
Latest spending
£16.0m
Registered
2002
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the group's unrestricted reserves totalled £129,938,522, a significant increase from the previous year's £36,234,558, driven largely by a £90.1 million gain on the revaluation of investments in subsidiary companies. The trustees report that the charity maintains sufficient reserves to support current research, noting that the approach to reserve funds will be tailored to the post-acquisition strategy following the sale of its subsidiaries. The independent auditors confirmed that the financial statements are prepared on a going concern basis with no material uncertainties identified.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: sufficient reserves to enable the Charity to continue to support current research (reserves figure: £129.9m)
“It is the trustee’s policy to maintain sufficient reserves to enable the Charity to continue to support current research.” — page 7
Per its FY2025 accounts as filed with the Charity Commission.
Payments to trustees: An honorarium of £6,000 was payable to trustee J Alcock in the year (2024 £Nil).
“An honorarium of £6,000 was payable to trustee J Alcock in the year (2024 £Nil).” — page 27
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Dividends paid to directors of subsidiaries
“During the year, total dividends of £1,147,791 (2024 - £495,788) were paid to the directors of Medicines Evaluation Unit Limited and CRO Solutions Limited.” — page 36
“A Pickering Fellowship award was granted to the Manchester University NHS Foundation Trust in 2024 in respect of funding salary support for Trustee Dr H Badri. The initial grant amounted to £63,000, with an additional amount of £3,891 awarded during the year. A total of £33,543 was paid during the current year.” — page 36
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Grant to Trustee's employer
“During the year, total dividends of £1,147,791 (2024 - £495,788) were paid to the directors of Medicines Evaluation Unit Limited and CRO Solutions Limited.” — page 36
“A Pickering Fellowship award was granted to the Manchester University NHS Foundation Trust in 2024 in respect of funding salary support for Trustee Dr H Badri. The initial grant amounted to £63,000, with an additional amount of £3,891 awarded during the year. A total of £33,543 was paid during the current year.” — page 36
Per its FY2025 accounts as filed with the Charity Commission.
Trading subsidiary: Medicines Evaluation Unit Limited, CRO Solutions Limited
“The group financial statements consolidate the financial statements of the charitable company and its subsidiaries, Medicines Evaluation Unit Limited and CRO Solutions Limited on a line by line basis.” — page 19
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Mitchell Charlesworth (Audit) Limited. Discloses 3 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/03/2025

  • Trustee benefits, answered Yes to: any trustee benefit; other trustee benefit
  • Has a trading subsidiary
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/03/2024

  • Trustee benefits, answered Yes to: any trustee benefit; other trustee benefit
  • Has a trading subsidiary
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/03/2023

  • Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for services to the charity; other trustee benefit
  • Has a trading subsidiary
  • Grant-making is its main activity

Source: this charity’s annual returns on the Charity Commission register.

Annual return filing dates (Charity Commission record)

Of its last 5 annual returns with a recorded received date, 3 were received after the due date: year ending 31/03/2025 (received 30/03/2026, 58 days after the 31/01/2026 due date); year ending 31/03/2022 (received 18/07/2023, 168 days after the 31/01/2023 due date); year ending 31/03/2021 (received 22/07/2022, 172 days after the 31/01/2022 due date).

Due and received dates as recorded in the Commission’s annual-return data; the data does not say whether an extension was agreed. Source: this charity’s annual returns on the Charity Commission register.

Corporate structure

MEDICINES EVALUATION UNIT LIMITED — latest Companies House iXBRL filing (balance sheet 31 December 2025)
  • Profit/loss before tax: £2.6m
  • Equity: £975
  • Average employees: 1.6
CRO SOLUTIONS LIMITED — latest Companies House iXBRL filing (balance sheet 31 December 2025)
  • Profit/loss before tax: £700k
  • Equity: £1k
  • Average employees: 0.16
MEDICINES EVALUATION UNIT LIMITED — per its own Companies House accounts
  • Turnover: £18.2m
  • Profit before tax: £6.0m
CRO SOLUTIONS LIMITED — per its own Companies House accounts
  • Turnover: £7.2m
  • Profit before tax: £512k
  • Sales of £795,719 and purchases of £4,964,812 with Medicines Evaluation Unit Limited.

Public fundraising profile: JustGiving — North West Lung Centre Charity Ltd (matched by registered charity number).

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

Property (HM Land Registry)

2 registered titles in England and Wales held by the charity’s company or corporate body (0 freehold); recorded price paid £460k. All charity-held property. Contains HM Land Registry data © Crown copyright, OGL v3.0.

Structured financials (annual return, FY ending 31/03/2025)

Total income
£20.9m
Total spending
£16.0m
Cost of raising funds
£11k
Reserves (reported)
£129.9m
Employees
175

Reported reserves equal ~97.3 months of spending — in the top quarter for charities its size (median 4.6 months; benchmarks).

Per its annual return, largest income source: Other trading activities (94% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.1% of total income — below the median for charities its size (3.7%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England

Income and spending

Financial year endIncomeSpending
31/03/2025£20.9m£16.0m
31/03/2024£19.6m£13.0m
31/03/2023£19.0m£15.1m
31/03/2022£17.5m£13.1m
31/03/2021£15.9m£12.5m

Common questions

Is NORTH WEST LUNG CENTRE financially healthy?

Per its FY2025 accounts: The accounts state that the group's unrestricted reserves totalled £129,938,522, a significant increase from the previous year's £36,234,558, driven largely by a £90.1 million gain on the revaluation of investments in subsidiary companies. The trustees report that the charity maintains sufficient reserves to support current research, noting that the approach to reserve funds will be tailored to the post-acquisition strategy following the sale of its subsidiaries. The independent auditors confirmed that the financial statements are prepared on a going concern basis with no material uncertainties identified. Its FY2025 accounts were audited by Mitchell Charlesworth (Audit) Limited.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

FunderSimilar charities fundedAmount to them
ASSOCIATION OF NHS CHARITIES1£85k
THE RCN FOUNDATION1£30k
KUSUMA TRUST UK1£10k

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THE WEST FOUNDATION.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
NORTH WEST LUNG CENTRE£20.9m——unclear—no doubt
THE WEST FOUNDATION FY2025£77k—0above—no doubt
NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) FY2025£2.3m——above—no doubt
LONDON NORTH WEST HEALTHCARE CHARITABLE FUND FY2025£769k—3above—no doubt
WYTHENSHAWE HOSPITAL TRANSPLANT FUND FY2025£218k—0unclear—no doubt
MULTIPLE SCLEROSIS THERAPY CENTRE SOUTH WEST LIMITED FY2025£325k—0above—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.